Director Mahendra Shah resigns from Bolt Biotherapeutics board; Dupont added to two committees

Bolt Biotherapeutics, Inc.

Dr. Mahendra Shah notified his resignation on Dec 19, effective Dec 31, 2024, for personal reasons.
Shah's departure not due to any disagreement with the company's operations, policies, or practices.
Board appointed existing director Dr. Jakob Dupont to the Audit Committee and Nominating and Corporate Governance Committee, effective upon Shah's resignation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.